AAAAAA

   
Results: 1-13 |
Results: 13
Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection
Authors: Kotloff, KL Sztein, MB Wasserman, SS Losonsky, GA DiLorenzo, SC Walker, RI
Citation: Kl. Kotloff et al., Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection, INFEC IMMUN, 69(6), 2001, pp. 3581-3590
Safety and immunogenicity of increasing doses of a Clostridium difficile toroid vaccine administered to healthy adults
Authors: Kotloff, KL Wasserman, SS Losonsky, GA Thomas, W Nichols, R Edelman, R Bridwell, M Monath, TP
Citation: Kl. Kotloff et al., Safety and immunogenicity of increasing doses of a Clostridium difficile toroid vaccine administered to healthy adults, INFEC IMMUN, 69(2), 2001, pp. 988-995
Diminution of the anti-polyribosylribitol phosphate response to a combineddiphtheria-tetanus-acellular pertussis/Haemophilus influenzae type b vaccine by concurrent inactivated poliovirus vaccination
Authors: Rennels, MB Englund, JA Bernstein, DI Losonsky, GA Anderson, EL Pichichero, ME Munoz, FM Wolff, MC
Citation: Mb. Rennels et al., Diminution of the anti-polyribosylribitol phosphate response to a combineddiphtheria-tetanus-acellular pertussis/Haemophilus influenzae type b vaccine by concurrent inactivated poliovirus vaccination, PEDIAT INF, 19(5), 2000, pp. 417-423
Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines
Authors: Rennels, MB Deloria, MA Pichichero, ME Losonsky, GA Englund, JA Meade, BD Anderson, EL Steinhoff, MC Edwards, KM
Citation: Mb. Rennels et al., Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines, PEDIATRICS, 105(1), 2000, pp. K1-K6
Production of IFN-y and IL-10 to Shigella invasions by mononuclear cells from volunteers orally inoculated with a shiga toxin-deleted Shigella dysenteriae type 1 strain (vol 164, pg 2221, 2000)
Authors: Samandari, T Kotloff, KL Losonsky, GA Picking, WD Sansonetti, PJ Levine, MM Sztein, MB
Citation: T. Samandari et al., Production of IFN-y and IL-10 to Shigella invasions by mononuclear cells from volunteers orally inoculated with a shiga toxin-deleted Shigella dysenteriae type 1 strain (vol 164, pg 2221, 2000), J IMMUNOL, 165(8), 2000, pp. 4756-4756
Production of IFN-gamma and IL-10 to Shigella invasins by mononuclear cells from volunteers orally inoculated with a Shiga toxin-deleted Shigella dysenteriae type 1 strain
Authors: Samandari, T Kotloff, KL Losonsky, GA Picking, WD Sansonetti, PJ Levine, MM Sztein, MB
Citation: T. Samandari et al., Production of IFN-gamma and IL-10 to Shigella invasins by mononuclear cells from volunteers orally inoculated with a Shiga toxin-deleted Shigella dysenteriae type 1 strain, J IMMUNOL, 164(4), 2000, pp. 2221-2232
Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans
Authors: Kotloff, KL Noriega, FR Samandari, T Sztein, MB Losonsky, GA Nataro, JP Picking, WD Barry, EM Levine, MM
Citation: Kl. Kotloff et al., Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans, INFEC IMMUN, 68(3), 2000, pp. 1034-1039
Validation of a gastrointestinal explant system for measurement of mucosalantibody production
Authors: Losonsky, GA Fantry, GT Reymann, M Lim, Y
Citation: Ga. Losonsky et al., Validation of a gastrointestinal explant system for measurement of mucosalantibody production, CL DIAG LAB, 6(6), 1999, pp. 803-807
Palatability, reactogenicity and immunogenicity of engineered live oral cholera vaccine CVD 103-HgR in Chilean infants and toddlers
Authors: Lagos, R San Martin, O Wasserman, SS Prado, V Losonsky, GA Bustamante, C Levine, MM
Citation: R. Lagos et al., Palatability, reactogenicity and immunogenicity of engineered live oral cholera vaccine CVD 103-HgR in Chilean infants and toddlers, PEDIAT INF, 18(7), 1999, pp. 624-630
Hepatitis B vaccination of premature infants: A reassessment of current recommendations for delayed immunization
Authors: Losonsky, GA Wasserman, SS Stephens, I Mahoney, F Armstrong, P Gumpper, K Dulkerian, S West, DJ Gewolb, IH
Citation: Ga. Losonsky et al., Hepatitis B vaccination of premature infants: A reassessment of current recommendations for delayed immunization, PEDIATRICS, 103(2), 1999, pp. E141-E147
Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR
Authors: Lagos, R Fasano, A Wasserman, SS Prado, V Martin, OS Abrego, P Losonsky, GA Alegria, S Levine, MM
Citation: R. Lagos et al., Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR, J INFEC DIS, 180(5), 1999, pp. 1709-1712
Expanded safety and immunogenicity of a bivalent, oral, attenuated choleravaccine, CVD 103-HgR plus CVD 111, in United States military personnel stationed in Panama
Authors: Taylor, DN Sanchez, JL Castro, JM Lebron, C Parrado, CM Johnson, DE Tacket, CO Losonsky, GA Wasserman, SS Levine, MM Cryz, SJ
Citation: Dn. Taylor et al., Expanded safety and immunogenicity of a bivalent, oral, attenuated choleravaccine, CVD 103-HgR plus CVD 111, in United States military personnel stationed in Panama, INFEC IMMUN, 67(4), 1999, pp. 2030-2034
Validation and characterization of a human volunteer challenge model for cholera by using frozen bacteria of the new Vibrio cholerae epidemic serotype, O139
Authors: Cohen, MB Giannella, RA Losonsky, GA Lang, DR Parker, S Hawkins, JA Gunther, C Schiff, GA
Citation: Mb. Cohen et al., Validation and characterization of a human volunteer challenge model for cholera by using frozen bacteria of the new Vibrio cholerae epidemic serotype, O139, INFEC IMMUN, 67(12), 1999, pp. 6346-6349
Risultati: 1-13 |